Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hermanns

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Bioconjugate Chemistry|December 18, 2013
IL-4 analogues with site-specific chemical modification at position 121 inhibit IL-4 and IL-13 biological activitiesViswanadham Duppatla, Maja Gjorgjevikj, Werner Schmitz, et al.
Clinical Toxicology (Philadelphia, Pa.)|March 1, 2005
Experiences of a poison center network with renal insufficiency in acetaminophen overdose: an analysis of 17 casesM A von Mach, M Hermanns-Clausen, I Koch, et al.
The Journal of Biological Chemistry|February 7, 2006
Oncostatin M receptor-mediated signal transduction is negatively regulated by SOCS3 through a receptor tyrosine-independent mechanismClaudia Stross, Simone Radtke, Thomas Clahsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999
Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130H M Hermanns, S Radtke, C Haan, et al.
The Journal of Biological Chemistry|January 12, 2002
Novel role of Janus kinase 1 in the regulation of oncostatin M receptor surface expressionSimone Radtke, Heike M Hermanns, Claude Haan, et al.
Cell Death & Disease|January 21, 2025
TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptorsJennifer Wagner, David Vredevoogd, Xin Yu, et al.
Oncogene|May 21, 2013
Control of gp130 expression by the mitogen-activated protein kinase ERK2N A Bonito, J Drechsler, S Stoecker, et al.
Cellular Signalling|February 3, 2005
The tyrosine 974 within the LIF-R-chain of the gp130/LIF-R heteromeric receptor complex mediates negative regulation of LIF signallingThomas Clahsen, Ute Lehmann, Claudia Stross, et al.
European Journal of Immunology|March 31, 2022
Flt3L, LIF, and IL-10 combination promotes the selective in vitro development of ESAM<sup>low</sup> cDC2B from murine bone marrowLaura Cyran, Julia Serfling, Luisa Kirschner, et al.
Circulation Research|September 8, 2012
CLP36 is a negative regulator of glycoprotein VI signaling in plateletsShuchi Gupta, Attila Braun, Martina Morowski, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Bioconjugate Chemistry|December 18, 2013
IL-4 analogues with site-specific chemical modification at position 121 inhibit IL-4 and IL-13 biological activitiesViswanadham Duppatla, Maja Gjorgjevikj, Werner Schmitz, et al.
Clinical Toxicology (Philadelphia, Pa.)|March 1, 2005
Experiences of a poison center network with renal insufficiency in acetaminophen overdose: an analysis of 17 casesM A von Mach, M Hermanns-Clausen, I Koch, et al.
The Journal of Biological Chemistry|February 7, 2006
Oncostatin M receptor-mediated signal transduction is negatively regulated by SOCS3 through a receptor tyrosine-independent mechanismClaudia Stross, Simone Radtke, Thomas Clahsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999
Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130H M Hermanns, S Radtke, C Haan, et al.
The Journal of Biological Chemistry|January 12, 2002
Novel role of Janus kinase 1 in the regulation of oncostatin M receptor surface expressionSimone Radtke, Heike M Hermanns, Claude Haan, et al.
Cell Death & Disease|January 21, 2025
TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptorsJennifer Wagner, David Vredevoogd, Xin Yu, et al.
Oncogene|May 21, 2013
Control of gp130 expression by the mitogen-activated protein kinase ERK2N A Bonito, J Drechsler, S Stoecker, et al.
Cellular Signalling|February 3, 2005
The tyrosine 974 within the LIF-R-chain of the gp130/LIF-R heteromeric receptor complex mediates negative regulation of LIF signallingThomas Clahsen, Ute Lehmann, Claudia Stross, et al.
European Journal of Immunology|March 31, 2022
Flt3L, LIF, and IL-10 combination promotes the selective in vitro development of ESAM<sup>low</sup> cDC2B from murine bone marrowLaura Cyran, Julia Serfling, Luisa Kirschner, et al.
Circulation Research|September 8, 2012
CLP36 is a negative regulator of glycoprotein VI signaling in plateletsShuchi Gupta, Attila Braun, Martina Morowski, et al.
Pageof 11